Omega Diagnostics Group Plc. (ODX.L) said that it expects revenue for the year ended 31 March 2010 to be marginally lower than its previous expectations. The company also said that there will be a consequential impact on adjusted profit before tax.
Earlier, the board indicated that additional growth in Genarrayt sales depended on a resolution to improving the method of manufacturing of these slides. The Board has been continually reviewing the capabilities of the non-contact printing system for manufacturing the Genarrayt slides on a consistent basis.
However, following a further technical review of the process today the Board has concluded that until the issues with the manufacturing process are fully resolved the Company will revert solely to the previous manufacturing method. Under the previous manufacturing method the number of slides that can be manufactured is lower than using the non-contact printing system, the company said.
For comments and feedback: editorial@rttnews.com